Neoadjuvant Chemotherapy Followed by Interval Debulking for Advanced-Stage Endometrial Cancer: Survival Outcome Based on Surgical and Molecular Characteristics

Mira Kheil, Tariq Mekkaoui, Emily Andresan, Gloria Fung, Madison Miller, Jamie G. Joseph, Anqi Wang, Ali Al Asadi, Mohamed Elshaikh, Sarfraz Ahmad, Ahmad Awada · 2026

Read Neoadjuvant Chemotherapy Followed by Interval Debulking for Advanced-Stage Endometrial Cancer: Survival Outcome Based on Surgical and Molecular Characteristics by Mira Kheil, Tariq Mekkaoui, Emily Andresan, Gloria Fung, Madison Miller, Jamie G. Joseph, Anqi Wang, Ali Al Asadi, Mohamed Elshaikh, Sarfraz Ahmad, Ahmad Awada (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13511075.txt.

Description

Mira Kheil and ten co-authors review outcomes when chemotherapy comes before surgery for advanced cancer of the womb lining, in 2026 work. Many such patients arrive with disease that cannot be removed safely at once, so drugs are given first to shrink the cancer. The team studied records of 42 patients who received that sequence and then had interval surgery to remove leftover tumor.

Most patients saw their tumors shrink after chemotherapy, and more than eight in ten had no visible tumor left after surgery. No single patient trait or molecular feature predicted survival once other factors were counted. Tumor shrinkage and full removal each hinted at links to longer time without the cancer returning. The authors add their results to growing support for drug-first care in chosen patients and call for larger studies to pin down who benefits most.

Catalog record

CREATORMira Kheil, Tariq Mekkaoui, Emily Andresan, Gloria Fung, Madison Miller, Jamie G. Joseph, Anqi Wang, Ali Al Asadi, Mohamed Elshaikh, Sarfraz Ahmad, Ahmad Awada
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE24 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13511075

Browse the full library · About the Tower of Babel